Cargando…

Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study

BACKGROUND: It has been suggested that apolipoprotein E (APOE) polymorphisms are associated with the risk of developing inflammatory bowel disease (IBD) and the early age of disease onset. However, there are no reports regarding the relationship with clinical characteristics and disease severity. AI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glapa-Nowak, Aleksandra, Szczepanik, Mariusz, Iwańczak, Barbara, Kwiecień, Jarosław, Szaflarska-Popławska, Anna Barbara, Grzybowska-Chlebowczyk, Urszula, Osiecki, Marcin, Dziekiewicz, Marcin, Stawarski, Andrzej, Kierkuś, Jarosław, Banasiewicz, Tomasz, Banaszkiewicz, Aleksandra, Walkowiak, Jarosław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047531/ https://www.ncbi.nlm.nih.gov/pubmed/33911469 http://dx.doi.org/10.3748/wjg.v27.i14.1483

Ejemplares similares

C-Reactive Protein/Albumin Ratio at Diagnosis of Pediatric Inflammatory Bowel Disease: A Retrospective Multi-Center Study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2022)

Genetic Variants of DMBT1 and SFTPD and Disease Severity in Paediatric Inflammatory Bowel Disease—A Polish Population-Based Study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2021)

Insolation and Disease Severity in Paediatric Inflammatory Bowel Disease—A Multi-Centre Cross-Sectional Study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2020)

HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children
por: Nowak, Jan Krzysztof, et al.
Publicado: (2021)

Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease—A Comparative Analysis Based on the Polish Pediatric Crohn’s and Colitis Cohort (POCOCO)
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2021)

Methylation of RUNX3 Promoter 2 in the Whole Blood of Children with Ulcerative Colitis
por: Dybska, Emilia, et al.
Publicado: (2022)

Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease
por: Nowak, Jan K., et al.
Publicado: (2014)

Immune response to hepatitis B vaccination in pediatric patients with inflammatory bowel disease
por: BARANOWSKA-NOWAK, MARTA, et al.
Publicado: (2020)

Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases—Randomized Placebo-Controlled Multicenter Trial
por: Pietrzak, Anna, et al.
Publicado: (2022)

Comparison of fecal pyruvate kinase isoform M2 and calprotectin in acute diarrhea in hospitalized children
por: Czub, Elzbieta, et al.
Publicado: (2014)

The risk of cardiovascular complications in inflammatory bowel disease
por: Czubkowski, Piotr, et al.
Publicado: (2020)

Safety and Effectiveness of Vedolizumab for the Treatment of Pediatric Patients with Very Early Onset Inflammatory Bowel Diseases
por: Fabiszewska, Sylwia, et al.
Publicado: (2021)

Dual Biologic Therapy in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Retrospective Study
por: Wlazło, Magdalena, et al.
Publicado: (2022)

Butyric acid in functional constipation
por: Pituch, Aleksandra, et al.
Publicado: (2013)

Butyric acid in irritable bowel syndrome
por: Załęski, Andrzej, et al.
Publicado: (2013)

The protocol for a randomised-controlled trial of the evaluation of the tolerance and safety of early enteral nutrition in children after percutaneous endoscopic gastrostomy placement. (protocol version 09.01.2015)
por: Wiernicka, Anna, et al.
Publicado: (2016)

Three-dimensional High-resolution Anorectal Manometry in Children With Non-retentive Fecal Incontinence
por: Banasiuk, Marcin, et al.
Publicado: (2022)

Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases
por: Ostrowski, Jerzy, et al.
Publicado: (2019)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease
por: Matuszczyk, Małgorzata, et al.
Publicado: (2022)

Serum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet
por: Janas, Roman M., et al.
Publicado: (2016)

Early Enteral Nutrition in Paediatric Acute Pancreatitis—A Review of Published Studies
por: Bukowski, Jan Stanisław, et al.
Publicado: (2022)

Assessment of coeliac disease prevalence in patients with Down syndrome in Poland – a multi-centre study
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2016)

Atherosclerotic Risk Factors in Children with Celiac Disease
por: Rybak, Anna, et al.
Publicado: (2020)

Influenza vaccination coverage in children with inflammatory bowel disease
por: Banaszkiewicz, Aleksandra, et al.
Publicado: (2014)

Green tea extract decreases starch digestion and absorption from a test meal in humans: a randomized, placebo-controlled crossover study
por: Lochocka, Klaudia, et al.
Publicado: (2015)

Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data
por: Nowak, Jan K., et al.
Publicado: (2022)

A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
por: Warzecha, Joanna, et al.
Publicado: (2022)

Circulating brain-derived neurotrophic factor, leptin, neuropeptide Y, and their clinical correlates in cystic fibrosis: a cross-sectional study
por: Nowak, Jan K., et al.
Publicado: (2018)

The Relationship between Eosinophil Density in the Colonic Mucosa and Eosinophil Blood Count in Children: A Cross-Sectional Study
por: Brylak, Jan, et al.
Publicado: (2022)

Exploring Physicians’ Perspectives on the Introduction of Complementary Foods to Infants and Toddlers
por: Dembiński, Łukasz, et al.
Publicado: (2021)

Crowdfunding Campaigns for Paediatric Patients: A Cross-sectional Analysis of Success Determinants
por: Kamiński, Mikołaj, et al.
Publicado: (2022)

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study
por: Szymanska, Edyta, et al.
Publicado: (2021)

Leukocyte Telomere Length Is Not Reduced in Children and Adults with Cystic Fibrosis but Associates with Clinical Characteristics—A Cross-Sectional Study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2021)

Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population
por: Ostrowski, Jerzy, et al.
Publicado: (2016)

To vaccinate or to isolate? Establishing which intervention leads to measurable mortality reduction during the COVID-19 Delta wave in Poland
por: Walkowiak, Marcin Piotr, et al.
Publicado: (2023)

Comparison of Subjective and Objective Methods to Measure the Physical Activity of Non-Depressed Middle-Aged Healthy Subjects with Normal Cognitive Function and Mild Cognitive Impairment—A Cross-Sectional Study
por: Makarewicz, Aleksandra, et al.
Publicado: (2021)

Nutritional Therapy in Pediatric Crohn’s Disease—Are We Going to Change the Guidelines?
por: Matuszczyk, Malgorzata, et al.
Publicado: (2021)

Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature
por: Wlazło, Magdalena, et al.
Publicado: (2022)

Lactose Malabsorption and Lactose Intolerance in Children with Inflammatory Bowel Diseases
por: Jasielska, Martyna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jnhnl4q05f3ebo9mubvsr0rkcq